+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast to 2030- Product Image
Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968616
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The over-the-counter consumer health products market is entering a pivotal phase, shaped by consumer preference for self-care, rapid digital adoption, and ongoing regulatory and supply chain shifts. Senior decision-makers in this sector need an actionable, high-level overview to make informed choices in a highly dynamic environment.

Market Snapshot of the Over-The-Counter Consumer Health Products Market

From 2024 to 2025, the over-the-counter consumer health products market is set for sustained growth, progressing from USD 220.52 billion to USD 235.16 billion. This growth trajectory is expected to persist through 2030, driven by a robust compound annual growth rate of 6.78% and projected to achieve USD 327.00 billion by the end of the decade. The expansion is underpinned by heightened consumer emphasis on self-care, an aging population, increasing demand for non-prescription health solutions, and developments in omnichannel retailing, which together are redefining the boundaries of this sector.

Scope & Segmentation

  • Product Types: Disinfectants, non-prescription drugs (including acne therapies, cold and allergy remedies, pain relievers), personal care and cosmetics, vitamins and supplements
  • Disease and Disorder Types: Allergy management, cardiovascular health, chronic pain, diabetes management, mental health and wellness (with sleep aids and stress relief), osteoporosis
  • Formulation Types: Gels and liquids, patch and transdermal, powders, tablets and capsules
  • Distribution Channels: Hospital and clinics, hypermarkets and supermarkets, retail pharmacies
  • Regional Coverage: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Participants: Major players including Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Reckitt Benckiser LLC, and Sanofi S.A., alongside specialized firms such as Amway Corporation, Dr. Reddy's Laboratories, Essity AB, and Sun Pharmaceuticals Ltd.

Key Takeaways for Decision-Makers

  • Consumer demand for products that promote preventive health and self-care is accelerating, positioning non-prescription formulations as essential parts of daily routines.
  • Evolving regulatory approaches, emphasizing faster approvals and stringent label scrutiny, are encouraging innovation while raising compliance requirements for emerging entrants.
  • The growing preference for transparent and sustainable sourcing, along with eco-friendly packaging, is influencing procurement decisions and enhancing brand differentiation among environmentally aware buyers.
  • Digital tools including telehealth, e-commerce platforms, and personalized wellness apps are expanding how end users discover, select, and purchase OTC health solutions, driving omnichannel strategy adoption.
  • Shifting consumer trust factors mean manufacturers must prioritize transparent communication, supply chain traceability, and effective engagement through digital and professional channels.
  • Strategic partnerships and advanced production methods—such as continuous manufacturing and microencapsulation—are unlocking new competitive advantages and accelerating time-to-market.

Tariff Impact and Supply Chain Resilience in 2025

Trade policy changes impacting the US market in 2025 are expected to challenge cost structures for categories reliant on imported ingredients and packaging materials. Additional tariffs on active components used in pharmaceuticals and supplements could pressure margins, especially for products with globalized sourcing models, such as specialized nutraceutical blends and transdermal patches. Manufacturers are taking a multipronged approach: considering reshoring production, renegotiating supplier contracts, and exploring alternative ingredients. These shifts are spurring increased investment in domestic manufacturing and supply chain diversification, with resilience and cost optimization emerging as crucial elements of long-term strategy.

Methodology & Data Sources

The analysis integrates primary interviews with senior executives across the value chain and a quantitative consumer survey. Secondary data sources include regulatory filings, company financials, industry association reports, and patent databases. All findings are thoroughly cross-validated and peer-reviewed to ensure reliability and strategic relevance for industry leadership.

Why This Report Matters

  • Enables leadership teams to align strategies with emerging consumer expectations, sustainability trends, and digital transformation in OTC health products.
  • Delivers a clear view of shifting regulatory landscapes, competitive tactics, supply chain vulnerabilities, and the impact of tariff changes.
  • Supports investment prioritization and risk management through up-to-date segmentation insights, regional trends, and technology adoption analysis.

Conclusion

The OTC consumer health products market is evolving with changing consumer priorities, regulatory norms, and complex trade environments. Leaders equipped with timely insights and resilient strategies will be best positioned to capture growth and mitigate emerging risks.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid integration of digital health tools and advanced analytics for enhanced product personalization and engagement
5.1.1.2. Rising consumer preference for self-medication and preventive health solutions to manage everyday health issues
5.1.2. Restraints
5.1.2.1. Ensuring efficient supply chain operations amid rising demand and regional market variabilities
5.1.3. Opportunities
5.1.3.1. Increased investment in research and development for innovative OTC formulations and delivery systems
5.1.3.2. Growing consumer interest in natural and plant-based OTC products fueled by wellness awareness and sustainability trends
5.1.4. Challenges
5.1.4.1. Complex regulatory landscape and lengthy approval processes impeding market expansion
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing need for pain relievers due to increasing incidences of lifestyle-related ailments
5.2.2. Distribution Channel: Growing consumer preference for hospitals & clinics due to immediate and professional healthcare advice
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Over-The-Counter Consumer Health Products Market, by Type
6.1. Introduction
6.2. Disinfectants
6.3. Non-prescription Drugs
6.3.1. Acne Therapies
6.3.2. Cold & Allergy Remedies
6.3.3. Pain Relievers
6.4. Personal Care & Cosmetics
6.5. Vitamin & Supplements
7. Over-The-Counter Consumer Health Products Market, by Disease/Disorder Type
7.1. Introduction
7.2. Allergy Management
7.3. Cardiovascular Health
7.4. Chronic Pain
7.5. Diabetes Management
7.6. Mental Health and Wellness
7.6.1. Sleep Aids
7.6.2. Stress Relief
7.7. Osteoporosis
8. Over-The-Counter Consumer Health Products Market, by Formulation Type
8.1. Introduction
8.2. Gels & Liquids
8.3. Patch & Transdermal
8.4. Powders
8.5. Tablets & Capsules
9. Over-The-Counter Consumer Health Products Market, by Distribution Channel
9.1. Introduction
9.2. Hospital & Clinics
9.3. Hypermarkets & Supermarkets
9.4. Retail Pharmacies
10. Americas Over-The-Counter Consumer Health Products Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Over-The-Counter Consumer Health Products Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Over-The-Counter Consumer Health Products Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Neutrogena partners with dermatologists for skincare innovation
13.3.2. Abhay HealthTech expands OTC reach with MNP healthcare acquisition
13.3.3. Piramal Pharma explores OTC partnerships amidst strategic debt reduction
13.3.4. NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
13.3.5. iNova to buy Mundipharma's consumer healthcare brands for USD 540 million
13.3.6. WellSpring Consumer Healthcare Acquires OTC Skin Care Brands from Bayer
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET MULTI-CURRENCY
FIGURE 2. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET MULTI-LANGUAGE
FIGURE 3. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET RESEARCH PROCESS
FIGURE 4. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET DYNAMICS
TABLE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ACNE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COLD & ALLERGY REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PAIN RELIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMIN & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STRESS RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 56. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 58. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 88. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 89. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 90. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 91. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 94. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 96. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 106. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 108. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 109. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 142. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 144. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 161. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 163. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 164. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 169. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 170. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 173. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 197. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 198. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 199. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 200. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 215. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 221. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 223. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 227. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 229. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 230. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 254. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NON-PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 269. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY OVER-THE-COUNTER CONS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Over-The-Counter Consumer Health Products market report include:
  • 3M Company
  • Abbott Laboratories
  • Amway Corporation
  • Archer Daniels Midland Company
  • B. Braun SE
  • Bayer AG
  • Beiersdorf AG
  • Boehringer Ingelheim GmbH
  • Cardinal Health, Inc.
  • Cipla Limited
  • Cosmetic Skin Solutions, LLC
  • Dr. Reddy's Laboratories
  • Essity AB
  • Estée Lauder Companies Inc.
  • FastFill Pack, Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • InSpec Solutions, LLC
  • Integra Lifesciences Corporation
  • Johnson & Johnson services, Inc.
  • Koninklijke DSM N.V.
  • L'Oréal SE
  • Lonza Group Ltd.
  • Medline Industries, Inc.
  • Mineral Mine
  • Mölnlycke Health Care AB
  • Nardo’s Natural, Inc. by by Barbara Corcoran
  • Natures Formulae Ltd.
  • Nestle SA
  • Nichiban Co., Ltd.
  • Onoxa LLC
  • Paul Hartmann AG
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser LLC
  • Sanofi S.A.
  • Smith & Nephew PLC
  • Sun Pharmaceuticals Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 235.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 327 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned40

Related Topics

Related Reports

Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Consumer Healthcare Market by Product Type, Distribution Channel, Form, End User, Therapeutic Area - Global Forecast to 2030 - Product Image

Consumer Healthcare Market by Product Type, Distribution Channel, Form, End User, Therapeutic Area - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Consumer Healthcare Market Report 2025 - Product Image

Consumer Healthcare Market Report 2025

  • Report
  • 200 Pages
  • Global
From
OTC Consumer Health - Global Strategic Business Report - Product Image

OTC Consumer Health - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
CBD Consumer Health Market by Product Type, Application - Global Forecast to 2030 - Product Image

CBD Consumer Health Market by Product Type, Application - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.